Pulmonary Atresia With Ventricular Septal Defect 

  • Author: Edwin Rodriguez-Cruz, MD; Chief Editor: Stuart Berger, MD   more...
 
Updated: Oct 29, 2010
 

Background

Pulmonary atresia with ventricular septal defect (PA-VSD) is a cyanotic congenital heart disease characterized by underdevelopment of the right ventricular (RV) outflow tract (ie, subpulmonary infundibulum) with atresia of the pulmonary valve, a large ventricular septal defect (VSD), and overriding of the aorta. In the past, this anomaly was termed pseudotruncus or truncus arterious type 4.

Pulmonary atresia with ventricular septal defect demonstrates a wide spectrum of severity, depending on the degree of pulmonary artery development. Pathologically, pulmonary atresia with ventricular septal defect is frequently considered the most severe end of the spectrum of tetralogy of Fallot (TOF), but whether pulmonary atresia with ventricular septal defect and TOF should be treated as 2 distinct entities is controversial. In patients with the standard type of TOF with pulmonary atresia, pulmonary arteries are usually normal in size with normal peripheral pulmonary arborization, which is unlike pulmonary atresia with ventricular septal defect. In addition, systemic-to-pulmonary collateral vessels are not as well developed in patients with TOF with pulmonary atresia as they are in patients with pulmonary atresia with ventricular septal defect.

Next

Epidemiology

Frequency

The best estimates of the relative frequency of pulmonary atresia with ventricular septal defect are 2.5-3.4% of all congenital cardiac malformations. Pulmonary atresia with ventricular septal defect is slightly more prevalent in males than in females.

Previous
Next

Etiology

The actual genetic cause of pulmonary atresia with ventricular septal defect is unknown. An association with velocardiofacial syndrome and DiGeorge syndrome has been found. Children of patients with pulmonary atresia with ventricular septal defect have a higher risk of having congenital heart lesions than children of parents without pulmonary atresia with ventricular septal defect.

Previous
Next

Pathophysiology

In pulmonary atresia with ventricular septal defect, the extent of pulmonary artery development determines the clinical presentation and the surgical options available. Pulmonary artery atresia may be local only, with involvement of the pulmonary valve and the proximal portion of the pulmonary trunk, or it may involve a longer segment. The right and left pulmonary arteries may communicate freely (ie, confluence) or may not communicate (ie, nonconfluence). Pulmonary circulation may be supplied by a patent ductus arteriosus (PDA), systemic-to-pulmonary collaterals, or plexuses of bronchial and pleural arteries.

The pathology of intrapulmonary arteries depends on the pulmonary blood flow and the patency of the ductus. If the ductus is large and supplies confluent pulmonary arteries, the blood flow and the intrapulmonary arteries of both lungs are normal. If collaterals are multiple and the ductus is congenitally absent, abnormal intrapulmonary arborization (ie, stenosis of unbranched and intrapulmonary arteries) and pulmonary hypertension are present.

Collateral arteries most commonly arise from the thoracic aorta and less commonly arise from subclavian arteries, internal mammary arteries, intercostal arteries, or the abdominal aorta. Rarely, the collateral arteries arise from coronary arteries. In 60% of patients, the collateral arteries are stenosed at the aortic end or at intrapulmonary sites, and stenosis tends to progress over time.

The ventricular septal defect may be membranous or infundibular, is usually very large, and rarely is obstructed by membranous tissue. In 50% of patients, a secundum-type atrial septal defect (ASD) or a patent foramen ovale (PFO) is also present. In 26-50% of patients, the aorta arises predominantly from the RV and a dilated right-sided aortic arch may be present.

The RV and, to a lesser extent, the right atrium usually are moderately to markedly hypertrophied and dilated. The left atrium and left ventricle (LV) are usually normal. The coronary arteries are usually normal, although anomalies have been observed, such as a high origin of the coronary ostia, coronary artery–to–pulmonary artery fistulae,[1] and transposition anatomy with the right coronary artery originating from the left anterior aortic sinus and transversing the right ventricular infundibulum. Other associations include tricuspid atresia or stenosis, complete atrioventricular (AV) canal, complete or corrected transposition of the great arteries, left superior vena cava, anomalies of the coronary sinus, dextrocardia, and asplenia or polysplenia syndrome.

Classification

  • Type A: Pulmonary blood flow is provided by native pulmonary arteries.
  • Type B: Pulmonary blood flow is supplied by native pulmonary arteries and by major aortopulmonary collateral arteries.
  • Type C: Pulmonary blood flow is provided by major aortopulmonary collateral arteries.
Previous
Next

Presentation

The age at presentation may vary depending on the amount of pulmonary blood flow. However, the great majority of patients present in the newborn period after the closure of the ductus arteriosus. If collateral vessels are well developed, presentation may be delayed, although rarely.

The vast majority of patients present with cyanosis and hypoxia. Hypoxia is usually severe and is present when the entire pulmonary flow is reduced and a closing ductus arteriosus is the only source of pulmonary blood flow. If systemic collateral arteries are well developed or if the PDA is wide open, hypoxia is not severe in neonates. Patients may present with progressive hypoxia later because growth outstrips the pulmonary blood flow.

Rarely, an infant with a large PDA or well-developed systemic collateral arteries may present at age 4-6 weeks with heart failure with increased pulmonary blood flow and minimal cyanosis. This heart failure may be very difficult to control medically. Paroxysms of dyspnea and squatting occasionally occur in older children.

Hemoptysis may occur as a result of rupture of extensive systemic-to-pulmonary collateral arteries. Important and recurrent infections can occur because of immunodeficiency, especially if associated with DiGeorge syndrome. Survival to adulthood has been described in a few patients with well-developed collateral arteries.

Growth and development are usually delayed secondary to cyanosis or congestive heart failure (CHF).

Central (ie, perioral) cyanosis is usually mild at birth, but it becomes very severe with the closure of the PDA. Cyanosis may fluctuate for the first few days because the ductus arteriosus may constrict and relax intermittently. The patient may have anomalies of the face, palate, and ears as described in velocardiofacial syndrome. Peripheral pulses are usually normal in neonates and remain normal in cyanotic infants. In infants with wide-open PDAs, well-developed systemic collateral arteries, or surgically created shunts, pulses may become pronounced after 4-6 weeks because of a wide pulse pressure.

Signs of heart failure are rare. Heart pulsation is most prominent at the left lower sternal border. Heart size is usually normal. A prominent a wave in the jugular pulse may be found. The following may be observed on auscultation:

  • S1 is normal; S2 (ie, aortic valve closure) is always single and often accentuated. A grade 3/6 systolic murmur usually is audible along the lower left sternal border.
  • A continuous murmur is best heard over the upper chest in the presence of a PDA.
  • If systemic-to-pulmonary collateral arteries are present, continuous murmurs may be diffusely audible over the entire chest and back.
  • In some patients with severe cyanosis, no murmur can be heard.
  • An early diastolic murmur of aortic regurgitation may be noted.

Distinguishing characteristics for the diagnosis of pulmonary atresia with ventricular septal defect can be divided into 2 major groups, as follows:

  • Decreased pulmonary blood flow in a neonate with cyanosis
  • Normal or increased pulmonary blood flow in a neonate with minimal cyanosis with or without heart failure
    • Ventricular septal defect
    • PDA
    • AV canal defect
    • A double-outlet RV without significant pulmonary stenosis
    • A single ventricle without significant pulmonary stenosis
    • Persistent truncus arteriosus
    • Total anomalous pulmonary venous connection without pulmonary venous obstruction

Consult a pediatric cardiologist, a pediatric cardiothoracic surgeon, and a geneticist.

Previous
Next

Indications

Criteria for complete surgical repair of pulmonary atresia with ventricular septal defect (PA-VSD) are as follows:

  • If central pulmonary arteries are present, their central area must be more than 50% of normal for the patient's age and body surface area.
  • The pulmonary arteries must supply at least 10 segments, the equivalent of one lung.
  • If a single pulmonary artery is present, it must be normal in size and reach all segments of that lung.
Previous
Next

Contraindications

Contraindications for complete surgical repair of pulmonary atresia with ventricular septal defect include (1) hypoplastic or absent central pulmonary arteries and (2) inadequate peripheral arborization of pulmonary arteries.

Previous
Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Edwin Rodriguez-Cruz, MD  Assistant Professor, Department of Pediatrics, San Juan Bautista Medical School and Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Pediatrics, Hospital El Maestro and San Juan Bautista Medical Center; Consulting Interventional/Clinical Pediatric Cardiologist, Department of Cardiology, Cardiovascular Center of Puerto Rico and the Caribbean and Veterans Affairs Hospital and Medical Center of Puerto Rico

Edwin Rodriguez-Cruz, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Medical Association, American Society of Echocardiography, Puerto Rico Medical Association, Society of Cardiac Angiography and Interventions, and Society of Pediatric Echocardiography

Disclosure: NOVARTIS Grant/research funds INVESTIGATOR

Coauthor(s)

Sanjeev Aggarwal, MD, MBBS  Staff Physician, Department of Pediatrics, Children's Hospital of Michigan

Sanjeev Aggarwal, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics and American Medical Association

Disclosure: Nothing to disclose.

Ralph E Delius, MD  Associate Professor, Department of Surgery, Wayne State University

Ralph E Delius, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for Thoracic Surgery, American College of Chest Physicians, American College of Surgeons, American Heart Association, American Medical Association, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Specialty Editor Board

Jonah Odim, MD, PhD, MBA  Senior Medical Officer, Transplantation Immunology Branch, Division of Allergy, Immunology, and Transplantation, National Institute of Allergy and Infectious Diseases, National Institutes of Health

Jonah Odim, MD, PhD, MBA is a member of the following medical societies: American College of Cardiology, American College of Chest Physicians, American College of Physician Executives, American College of Surgeons, American Heart Association, American Society for Artificial Internal Organs, American Society of Transplant Surgeons, Association for Academic Surgery, Association for Surgical Education, Canadian Cardiovascular Society, International Society for Heart and Lung Transplantation, National Medical Association, New York Academy of Sciences, Royal College of Physicians and Surgeons of Canada, Society of Critical Care Medicine, and Society of Thoracic Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Mary C Mancini, MD, PhD  Professor and Chief of Cardiothoracic Surgery, Department of Surgery, Louisiana State University School of Medicine in Shreveport

Mary C Mancini, MD, PhD is a member of the following medical societies: American Association for Thoracic Surgery, American College of Surgeons, American Surgical Association, Phi Beta Kappa, Society of Thoracic Surgeons, and Southern Surgical Association

Disclosure: Nothing to disclose.

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Stuart Berger, MD  Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

References
  1. Collison SP, Dagar KS, Kaushal SK, Radhakrishanan S, Shrivastava S, Iyer KS. Coronary artery fistulas in pulmonary atresia and ventricular septal defect. Asian Cardiovasc Thorac Ann. Jan 2008;16(1):29-32. [Medline].

  2. Durongpisitkul K, Saiviroonporn P, Soongswang J, Laohaprasitiporn D, Chanthong P, Nana A. Pre-operative evaluation with magnetic resonance imaging in tetralogy of fallot and pulmonary atresia with ventricular septal defect. J Med Assoc Thai. Mar 2008;91(3):350-5. [Medline].

  3. Parker RI. Blood transfusions in patients with 22q11.2 deletion syndrome: assessment of risk requires identification of the at-risk patient. Pediatr Crit Care Med. Sep 2007;8(5):502-3. [Medline].

  4. Beauchesne LM, Warnes CA, Connolly HM, et al. Prevalence and clinical manifestations of 22q11.2 microdeletion in adults with selected conotruncal anomalies. J Am Coll Cardiol. Feb 15 2005;45(4):595-8. [Medline].

  5. Bharati S, Paul MH, Idriss FS, et al. The surgical anatomy of pulmonary atresia with ventricular septal defect: pseudotruncus. J Thorac Cardiovasc Surg. May 1975;69(5):713-21. [Medline].

  6. Black MD, Shukla V, Freedom RM. Direct neonatal ventriculo-arterial connections (REV): early results and future implications. Ann Thorac Surg. Apr 1999;67(4):1137-41. [Medline].

  7. Calvani M, Aiuti F, Marconi M, Franchi F, Talamo D. [Thymus dysplasia with circulating T-lymphocytes but not responsive to mitogen. Post-transfusional fatal graft-versus-host disease]. Minerva Pediatr. Nov 15 1979;31(21):1555-64. [Medline].

  8. d'Udekem Y, Alphonso N, Norgaard MA, et al. Pulmonary atresia with ventricular septal defects and major aortopulmonary collateral arteries: unifocalization brings no long-term benefits. J Thorac Cardiovasc Surg. Dec 2005;130(6):1496-502. [Medline].

  9. de Groot NM, Schalij MJ. Foetal echocardiography: tool to predict the future of patients with congenital heart defects?. Eur Heart J. Jun 2008;29(11):1344-5. [Medline].

  10. Dodds GA 3rd, Warnes CA, Danielson GK. Aortic valve replacement after repair of pulmonary atresia and ventricular septal defect or tetralogy of Fallot. J Thorac Cardiovasc Surg. Apr 1997;113(4):736-41. [Medline].

  11. El-Said HG, Clapp S, Fagan TE, et al. Stenting of stenosed aortopulmonary collaterals and shunts for palliation of pulmonary atresia/ventricular septal defect. Catheter Cardiovasc Interv. Apr 2000;49(4):430-6. [Medline].

  12. Faletra F, Giardina A, Petroni R, Carraro C, Pasotti E, Pedrazzini G, et al. Evaluation of pulmonary atresia with 64-slice multidetector computed tomography (MDCT). Echocardiography. Oct 2007;24(9):998-9. [Medline].

  13. Fiane AE, Lindberg HL, Seem E, Geiran OR. Homografts for right ventricular outflow tract reconstruction in congenital heart disease. Scand Cardiovasc J. 1997;31(6):351-6. [Medline].

  14. Gill CC, Moodie DS, McGoon DC. Staged surgical management of pulmonary atresia with diminutive pulmonary arteries. J Thorac Cardiovasc Surg. Mar 1977;73(3):436-42. [Medline].

  15. Hausdorf G, Schneider M, Schulze-Neick I, Lange PE. [Pulmonary valve atresia with ventricular septum defect: interventional recanalization of the right ventricular outflow tract]. Z Kardiol. Sep 1992;81(9):496-9. [Medline].

  16. Horer J, Friebe J, Schreiber C, et al. Correction of tetralogy of Fallot and of pulmonary atresia with ventricular septal defect in adults. Ann Thorac Surg. Dec 2005;80(6):2285-91. [Medline].

  17. Huhta JC, Piehler JM, Tajik AJ, et al. Two dimensional echocardiographic detection and measurement of the right pulmonary artery in pulmonary atresia-ventricular septal defect: angiographic and surgical correlation. Am J Cardiol. Apr 1 1982;49(5):1235-40. [Medline].

  18. Jedele KB, Michels VV, Puga FJ, Feldt RH. Velo-cardio-facial syndrome associated with ventricular septal defect, pulmonary atresia, and hypoplastic pulmonary arteries. Pediatrics. May 1992;89(5 Pt 1):915-9. [Medline].

  19. Julsrud PR. Magnetic resonance imaging of the pulmonary arteries and veins. Semin Ultrasound CT MR. Jun 1990;11(3):184-205. [Medline].

  20. Lim ZS, Vettukattill JJ, Salmon AP, Veldtman GR. Sildenafil therapy in complex pulmonary atresia with pulmonary arterial hypertension. Int J Cardiol. Nov 12 2007;[Medline].

  21. Mair DD, Julsrud PR. Diagnostic evaluation of pulmonary atresia and ventricular septal defect: Cardiac catheterization and angiography. Prog Pediatr Cardiol. 1992;1(1):23-36.

  22. Mohammadi S, Belli E, Martinovic I, et al. Surgery for right ventricle to pulmonary artery conduit obstruction: risk factors for further reoperation. Eur J Cardiothorac Surg. Aug 2005;28(2):217-22. [Medline].

  23. Najm HK, Jha NK, Godman M, Al Mutairi M, Rezk AI, Momenah T. Pulmonary atresia, VSD in association with coronary-pulmonary artery fistula. Asian Cardiovasc Thorac Ann. Aug 2007;15(4):335-8. [Medline].

  24. Puga FJ. Surgical treatment of pulmonary atresia and ventricular septal defect. Prog Pediatr Cardiol. 1992;1(1):37-49.

  25. Rabinovitch M, Herrera-deLeon V, Castaneda AR, Reid L. Growth and development of the pulmonary vascular bed in patients with tetralogy of Fallot with or without pulmonary atresia. Circulation. Dec 1981;64(6):1234-49. [Medline].

  26. Reddy VM, McElhinney DB, Amin Z, et al. Early and intermediate outcomes after repair of pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries: experience with 85 patients. Circulation. Apr 18 2000;101(15):1826-32. [Medline].

  27. Reichenspurner H, Netz H, Uberfuhr P, et al. Heart-lung transplantation in a patient with pulmonary atresia and ventricular septal defect. Ann Thorac Surg. Jan 1994;57(1):210-2. [Medline].

  28. Schulze-Neick I, Ho SY, Bush A, et al. Severe airflow limitation after the unifocalization procedure: clinical and morphological correlates. Circulation. Nov 7 2000;102(19 Suppl 3):III142-7. [Medline].

  29. Tchervenkov CI, Roy N. Congenital Heart Surgery Nomenclature and Database Project: pulmonary atresia--ventricular septal defect. Ann Thorac Surg. Apr 2000;69(4 Suppl):S97-105. [Medline].

  30. Tchervenkov CI, Salasidis G, Cecere R, et al. One-stage midline unifocalization and complete repair in infancy versus multiple-stage unifocalization followed by repair for complex heart disease with major aortopulmonary collaterals. J Thorac Cardiovasc Surg. Nov 1997;114(5):727-35; discussion 735-7. [Medline].

  31. Tireli E, Ugurlucan M, Banach M. eComment: The anastomosis between aorta and extension conduit of the pulmonary artery. Interact Cardiovasc Thorac Surg. Apr 2008;7(2):194. [Medline].

Previous
Next
 
Left ventricular angiography (right anterior oblique caudal view) in a patient with pulmonary atresia with ventricular septal defect (PA-VSD). The catheter has been advanced from the inferior vena cava to the right atrium, across the atrial septal defect to the left atrium, and then to the left ventricle. The left ventricle fills with contrast and has good systolic function. Left-to-right shunting of contrast is present across a ventricular septal defect; however, no blood is flowing out the right ventricle. A blind pouch is observed in the area of the right ventricular outflow tract. All of the contrast medium (flow) exits the heart via the aorta. The pulmonary circulation is supplied by collateral vessels arising from the descending aorta. See Media files 2-3 for still frames.
Left anterior oblique ventriculogram in a patient (same patient as Media files 1-3) with pulmonary atresia with ventricular septal defect (PA-VSD). The angiogram shows the left and right ventricles with a large malalignment ventricular septal defect between them. The only outflow from the heart is the aorta. No evidence of pulmonary blood flow is observed arising from the ventricles directly to the lungs. LV=left ventricle; RV=right ventricle; Asc Ao=ascending aorta; Desc Ao=descending aorta.
Anteroposterior view of an aortogram in a patient (same patient as Media files 1-2) with pulmonary atresia with ventricular septal defect (PA-VSD). The pulmonary circulation is supplied by collateral vessels (Collaterals) that arise from the descending aorta. Desc Ao=descending aorta.
Short-axis parasternal view in a patient with pulmonary atresia with ventricular septal defect (PA-VSD). Note the trileaflet aortic valve in the center of the picture. The tricuspid valve is on the left (9- to 10-o'clock position). The normal pulmonary valve position is on the right (2- to 3-o'clock position). This echocardiogram demonstrates that the pulmonary valve is atretic. See Media file 5 for a still frame.
Short-axis parasternal view (1) and diagram (3) in a patient with pulmonary atresia and ventricular septal defect (PA-VSD). Short-axis parasternal view (2) and diagram (4) in a patient with normal anatomy. RA=right atrium; LA=left atrium; RV=right ventricle; PA=pulmonary artery; TR=tricuspid valve; PV=pulmonary valve.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.